Save your place

Sign in to WhoBought

Please try again later.

Forte Biosciences, Inc. (FBRX) institutional ownership

Latest close $47.49 Jul 20, 2026
Market cap$136M 52-week range SectorHealthcare
Funds holding · Q3 2024
33
reported FBRX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q3 2024
Net sold $194M
0 buyers · 33 sellers

Forte Biosciences, Inc. (FBRX) price and institutional activity

Dates

Q3 2024

$0 bought by 0 investors
$194M sold by 33 investors
Tybourne Capital Management (hk) Ltd-$37MPerceptive Advisors LLC-$34M +31 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Forte Biosciences, Inc. (FBRX) institutional activity · 33

Investor Type Est. change Change Δ Own Date
Tybourne Capital Management (hk) Ltd · Exited −$37M
Change −3.6M Δ Own −100.0% Date Q3 2024
Tybourne Capital Management (hk) Ltd Exited· Q3 2024 −$37M −3.6M −100.0% Q3 2024
Perceptive Advisors LLC · Exited −$34M
Change −3.3M Δ Own −100.0% Date Q3 2024
Perceptive Advisors LLC Exited· Q3 2024 −$34M −3.3M −100.0% Q3 2024
Bvf Inc · Exited −$31M
Change −3.0M Δ Own −100.0% Date Q3 2024
Bvf Inc Exited· Q3 2024 −$31M −3.0M −100.0% Q3 2024
Cable Car Capital, LP · Exited −$21M
Change −2.0M Δ Own −100.0% Date Q3 2024
Cable Car Capital, LP Exited· Q3 2024 −$21M −2.0M −100.0% Q3 2024
Fred Alger Management, LLC · Exited −$19M
Change −1.8M Δ Own −100.0% Date Q3 2024
Fred Alger Management, LLC Exited· Q3 2024 −$19M −1.8M −100.0% Q3 2024
Farallon Capital Management LLC · Exited −$19M
Change −1.8M Δ Own −100.0% Date Q3 2024
Farallon Capital Management LLC Exited· Q3 2024 −$19M −1.8M −100.0% Q3 2024
Bml Capital Management, LLC · Exited −$18M
Change −1.8M Δ Own −100.0% Date Q3 2024
Bml Capital Management, LLC Exited· Q3 2024 −$18M −1.8M −100.0% Q3 2024
Vanguard · Exited −$6.8M
Change −665K Δ Own −100.0% Date Q3 2024
Vanguard Exited· Q3 2024 −$6.8M −665K −100.0% Q3 2024
Geode · Exited −$3.6M
Change −346K Δ Own −100.0% Date Q3 2024
Geode Exited· Q3 2024 −$3.6M −346K −100.0% Q3 2024
Adar1 Capital Management, LLC · Exited −$1.6M
Change −159K Δ Own −100.0% Date Q3 2024
Adar1 Capital Management, LLC Exited· Q3 2024 −$1.6M −159K −100.0% Q3 2024
Renaissance Technologies LLC Exited· Q3 2024 −$1.4M −133K −100.0% Q3 2024
Two Sigma Investments, LP · Exited −$420K
Change −41K Δ Own −100.0% Date Q3 2024
Two Sigma Investments, LP Exited· Q3 2024 −$420K −41K −100.0% Q3 2024
State Street · Exited −$386K
Change −38K Δ Own −100.0% Date Q3 2024
State Street Exited· Q3 2024 −$386K −38K −100.0% Q3 2024
Susquehanna International Group, LLP · Exited −$353K
Change −34K Δ Own −100.0% Date Q3 2024
Susquehanna International Group, LLP Exited· Q3 2024 −$353K −34K −100.0% Q3 2024
Northern Trust · Exited −$276K
Change −27K Δ Own −100.0% Date Q3 2024
Northern Trust Exited· Q3 2024 −$276K −27K −100.0% Q3 2024
Data through Q3 2024 · filed Dec 26, 2024
15 of 33

Famous investor activity in Forte Biosciences, Inc. (FBRX)

Forte Biosciences, Inc. (FBRX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Riley Antony A. · Officer 2 operations 0
Owned 750 Trade date Jul 1, 2026 Filed date Jul 6, 2026
Riley Antony A. Officer 2 operations 0 750 Jul 1, 2026 Jul 6, 2026
Riley Antony A. · Officer Tax withholding or exercise payment (F) -$3K
Price $21.32 Qty -134 Owned 43K ΔOwn −0.3% Trade date Jul 1, 2026 Filed date Jul 6, 2026
Riley Antony A. Officer Tax withholding or exercise payment (F) $21.32 -134 -$3K 43K −0.3% Jul 1, 2026 Jul 6, 2026
Wagner Paul A. · Director 2 operations 0
Owned 2K Trade date Jul 1, 2026 Filed date Jul 6, 2026
Wagner Paul A. Director 2 operations 0 2K Jul 1, 2026 Jul 6, 2026
Wagner Paul A. · Director Tax withholding or exercise payment (F) -$2K
Price $21.32 Qty -98 Owned 85K ΔOwn −0.1% Trade date Jul 1, 2026 Filed date Jul 6, 2026
Wagner Paul A. Director Tax withholding or exercise payment (F) $21.32 -98 -$2K 85K −0.1% Jul 1, 2026 Jul 6, 2026
Riley Antony A. · CFO Grant (A) 22K
Owned 22K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Riley Antony A. CFO Grant (A) 22K 22K Jun 16, 2026 Jun 17, 2026
Wagner Paul A. · Director Grant (A) 500K
Owned 500K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Wagner Paul A. Director Grant (A) 500K 500K Jun 16, 2026 Jun 17, 2026
Doberstein Stephen K. · Director Grant (A) 18K
Owned 18K Trade date May 29, 2026 Filed date Jun 2, 2026
Doberstein Stephen K. Director Grant (A) 18K 18K May 29, 2026 Jun 2, 2026
Kapoor Shivpreet Singh · Director Grant (A) 18K
Owned 18K Trade date May 29, 2026 Filed date Jun 2, 2026
Kapoor Shivpreet Singh Director Grant (A) 18K 18K May 29, 2026 Jun 2, 2026
Vincent Richard G. · Director Grant (A) 18K
Owned 18K Trade date May 29, 2026 Filed date Jun 2, 2026
Vincent Richard G. Director Grant (A) 18K 18K May 29, 2026 Jun 2, 2026
Gryska David W. · Director Grant (A) 18K
Owned 18K Trade date May 29, 2026 Filed date Jun 2, 2026
Gryska David W. Director Grant (A) 18K 18K May 29, 2026 Jun 2, 2026
Brun Scott C. · Director Grant (A) 18K
Owned 18K Trade date May 29, 2026 Filed date Jun 2, 2026
Brun Scott C. Director Grant (A) 18K 18K May 29, 2026 Jun 2, 2026
Kornfeld Steven · Director Grant (A) 18K
Owned 18K Trade date May 29, 2026 Filed date Jun 2, 2026
Kornfeld Steven Director Grant (A) 18K 18K May 29, 2026 Jun 2, 2026
Riley Antony A. · CFO 2 operations 0
Owned 1K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Riley Antony A. CFO 2 operations 0 1K Apr 1, 2026 Apr 3, 2026
Riley Antony A. · CFO Tax withholding or exercise payment (F) -$3K
Price $24.86 Qty -134 Owned 42K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Riley Antony A. CFO Tax withholding or exercise payment (F) $24.86 -134 -$3K 42K Apr 1, 2026 Apr 3, 2026
Wagner Paul A. · Director 2 operations 0
Owned 4K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Wagner Paul A. Director 2 operations 0 4K Apr 1, 2026 Apr 3, 2026
15 of 27
15 of 27 Sign in to continue to older insider transactions.

Forte Biosciences, Inc. (FBRX) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Federated Hermes, Inc. 2.1M
% of shares outstanding 10.3% Filing date Jul 8, 2026
Federated Hermes, Inc. 2.1M 10.3% Jul 8, 2026
Alger Associates, Inc. 624K
% of shares outstanding 10.2% Filing date May 15, 2026
Alger Associates, Inc. 624K 10.2% May 15, 2026
Janus Henderson Group PLC 1.4M
% of shares outstanding 10.0% Filing date May 15, 2026
Janus Henderson Group PLC 1.4M 10.0% May 15, 2026
Tybourne Capital Management (hk) Ltd 1.3M
% of shares outstanding 10.0% Filing date Aug 4, 2025
Tybourne Capital Management (hk) Ltd 1.3M 10.0% Aug 4, 2025
Affinity Asset Advisors, LLC 1.0M
% of shares outstanding 7.3% Filing date May 14, 2026
Affinity Asset Advisors, LLC 1.0M 7.3% May 14, 2026
Mpm Bioimpact LLC 1.0M
% of shares outstanding 7.2% Filing date May 15, 2026
Mpm Bioimpact LLC 1.0M 7.2% May 15, 2026
Adage Capital Management, L.P. 950K
% of shares outstanding 6.8% Filing date May 13, 2026
Adage Capital Management, L.P. 950K 6.8% May 13, 2026
Biotechnology Value Fund L P 339K
% of shares outstanding 5.3% Filing date Feb 14, 2025
Biotechnology Value Fund L P 339K 5.3% Feb 14, 2025
8 of 17

Forte Biosciences, Inc. (FBRX) ownership FAQ

Who owns FBRX?

33 reporting institutions disclosed FBRX position changes in the Q3 2024 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q3 2024.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.